Acute Myeloid Leukemia (AML)
Also known as: Leukemia Acute Myeloid - AML / ACUTE MYELOID LEUKEMIA; AML / Leukemia, Myelogenous, Acute / Leukemia, Acute Myeloid (AML) / Acute Myeloid Leukemia NOS / Leukemia, Acute Myelogenous (AML) / Cancer - Acute Myeloid Leukemia (AML) / Acute Myeloid Leucemia / AML (Acute Myelogenous Leukemia / Myeloid Leukemia, Acute / Acute Myelogenous Leukemia / Leukemia Myeloid Acute / Acute Granulocytic Leukemia / AML (Acute Myelogenous Leukemia) / Leukemia, Myeloid, Acute(AML) / Acute Myeloid Leucaemia / Leukemia, Myeloid Acute / Acute Myelogenous Leukemia AML / Acute Myelogenous Leukemia (AML) / Acute Myeloid Leukaemias (AML) / Leukemia, Myeloid, Acute / Acute Leukemia, Myeloid / Leukaemia (Acute Myeloid) / AML - Acute Myeloid Leukemia / Acute Myeloid Leukaemia (AML) / Acute Myeloid Leukaemia / Acute Myeloid Leukemia / Leukemias, Acute Myeloid / Leukemia, Acute Myelogenous / Acute Myeloid Leukemia Leukemia / Myelogenous Leukemia, Acute / Leukaemias acute myeloid / Leukemia Acute Myeloid / Acute Myeloid Leukemias / Myeloid Leukemias, Acute / AML / Acute Myeloid Leukemia(AML) / Leukemia, Acute Myeloid / Leukemia Acute Myeloid Leukemia (AML) / Cancer - Acute Myeloid Leukemia / Acute myeloid leukemia, disease (disorder) / Acute myelocytic leukaemia / Acute myelocytic leukemia / Acute myeloid leukemia, no ICD-O subtype (morphologic abnormality) / Acute myeloblastic leukemia with failed remission / Leukaemia myeloblastic acute / [M]Acute myeloid leukaemia / Non-lymphoblastic leukaemia acute / Non-lymphoblastic leukemia acute / Myeloid leukaemia, acute / Acute myeloblastic leukemia, minimal differentiation / Acute myeloblastic leukemia / Acute myeloblastic leukemia (disorder) / Acute myeloblastic leukaemia / Leukemia myeloblastic acute / Acute granulocytic leukaemia / Acute myeloid leukemia - category (morphologic abnormality) / Acute myeloid leukaemia NOS
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00928 | Azacitidine | A pyrimidine nucleoside analogue used to treat certain subtypes of myelodysplastic syndrome. |
| DB00531 | Cyclophosphamide | A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. |
| DB00987 | Cytarabine | A pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. |
| DB00773 | Etoposide | A podophyllotoxin derivative used to treat testicular and small cell lung tumors. |
| DB00099 | Filgrastim | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. |
| DB00056 | Gemtuzumab ozogamicin | A monoclonal anti-CD33 antibody used to treat CD33-positive acute myeloid leukemia. |
| DB11978 | Glasdegib | A sonic hedgehog receptor inhibitor used to treat newly diagnosed acute myeloid leukemia in patients over 75 years who cannot receive intense chemotherapy. |
| DB01177 | Idarubicin | An anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults. |
| DB06595 | Midostaurin | An antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL). |
| DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
| DB00020 | Sargramostim | A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant. |
| DB01030 | Topotecan | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. |